Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Oral Maxillofac Surg ; 50(6): 504-7, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22119328

ABSTRACT

Patients with chronic myeloid leukaemia (CML) are at considerable risk of developing second primary neoplasms. However, mucosal squamous cell cancers (SCCs) of the head and neck have not been reported. We review the data of 7 patients with mucosal SCC of the head and neck that presented as metachronous second primary tumours in patients with CML. All 7 patients were men (median age 48 years, range 31-67) (site:oral cavity n=6, hypopharynx n=1). The median interval between diagnosis of CML and head neck cancer was 6 years (range 2-15). Treatment was curative in 4 and palliative in 3. At median follow up of 14 months (range 2-44), 3 patients had died of head and neck cancer, 1 of CML, and 3 were alive and free of disease. Mucosal cancers of the head and neck can occur in long-term survivors of CML. They are aggressive and tend to recur.


Subject(s)
Carcinoma, Squamous Cell/pathology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Mouth Neoplasms/pathology , Neoplasms, Second Primary/pathology , Adult , Aged , Antineoplastic Agents/therapeutic use , Benzamides , Cause of Death , Disease-Free Survival , Follow-Up Studies , Gingival Neoplasms/pathology , Humans , Hydroxyurea/therapeutic use , Hypopharyngeal Neoplasms/pathology , Imatinib Mesylate , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy , Male , Middle Aged , Palliative Care , Piperazines/therapeutic use , Protein Kinase Inhibitors/therapeutic use , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrimidines/therapeutic use , Time Factors , Tongue Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...